September 20, 2021

FDA committee votes against COVID-19 vaccine boosters for general population

By: Judy Mathias

Editor's Note

The Food and Drug Administration’s (FDA’s) Vaccines and Related Biological Products Advisory Committee on September 17 voted that there was not enough safety and effectiveness data to approve a third Pfizer COVID-19 vaccine dose for those 16 years and older.

The committee did vote to recommend approval of a booster dose for people 65 years and older and those at high risk of severe COVID-19.

Sponsored Message

The committee also recommended approval of a booster for those with occupational risks, such as healthcare workers and teachers.


Get OR Manager Updates

Sign Up Now
Latest Issue of OR Manager
December 2021
Video Spotlight
Live chat by BoldChat